Home › Companies › TRANSMEDICS GROUP INC. › 2023-2024

TRANSMEDICS GROUP INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TRANSMEDICS GROUP INC.’s Form 8-K, filed 2024-05-28 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 11Reported items
  • 281Asset managers
  • 2,832Fund votes
  • 2024-05-23Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TRANSMEDICS GROUP INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TRANSMEDICS GROUP INC.

These tallies are TRANSMEDICS GROUP INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-28 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TRANSMEDICS GROUP INC. — official shareholder meeting results, meeting held 2024-05-23
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Waleed Hassanein, M.D 24,024,298208,9477,690 --2,988,846 Majority: yes
Elect Director: James R. Tobin 23,518,088711,23911,608 --2,988,846 Majority: yes
Elect Director: Edward M. Basile 19,849,6034,379,66411,668 --2,988,846 Majority: yes
Elect Director: Thomas J. Gunderson 23,873,171356,02311,741 --2,988,846 Majority: yes
Elect Director: Edwin M. Kania, Jr. 23,550,271679,02311,641 --2,988,846 Majority: yes
Elect Director: Stephanie Lovell 23,789,019441,90510,011 --2,988,846 Majority: yes
Elect Director: Merilee Raines 23,928,824302,04010,071 --2,988,846 Majority: yes
Elect Director: David Weill, M.D. 23,735,272494,17511,488 --2,988,846 Majority: yes
Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes: 22,902,3591,321,62716,949 --2,988,846 Majority: yes

This meeting is also recorded here as 2024-05-24; both records come from the same filing, so the date should be checked against it.

Source: TRANSMEDICS GROUP INC., Form 8-K, filed with the SEC on 2024-05-28 — read the filing on EDGAR.

How asset managers voted at the TRANSMEDICS GROUP INC. 2023-2024 meeting

Each item below shows how the 281 asset managers that disclosed a TRANSMEDICS GROUP INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TRANSMEDICS GROUP INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 17 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 22,902,359AGAINST: 1,321,627

TRANSMEDICS GROUP INC.’s own tally for this item (“Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:”): 22,902,359 for, 1,321,627 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 70% for, 4% against (74% of the company cast a for/against vote).

The 277 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 97%
FOR: 96.7%AGAINST: 3.3%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity8,016,648156,998 00For
Vanguard2,403,3310 00For
Invesco1,629,2930 00For
BlackRock1,324,6530 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST1,181,3780 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Allspring962,3780 00For
ArrowMark Colorado Holdings LLC886,8410 00For
Delaware/Macquarie828,0830 00For
DRIEHAUS CAPITAL MANAGEMENT LLC809,9870 00For
UBS0694,478 00Against
First Light Asset Management, LLC673,0680 00For
MACKENZIE FINANCIAL CORP666,2860 00For
State Street547,0170 00For
Charles Schwab514,6480 00For
T. Rowe Price471,0490 00For
LORD, ABBETT & CO. LLC457,3270 00For
EMERALD MUTUAL FUND ADVISERS TRUST370,0140 00For
Lord Abbett358,6790 00For
GEODE CAPITAL MANAGEMENT, LLC349,3180 00For
Royce315,1980 00For
WASATCH ADVISORS LP307,2630 00For
Eagle Health Investments LP278,6550 00For
WASATCH FUNDS TRUST267,6280 00For
FULLER & THALER ASSET MANAGEMENT, INC.264,5590 00For

Showing the 25 largest of 277 asset managers. See all 277 in the interactive database.

2. Election of Directors: Waleed Hassanein, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 24,024,298AGAINST: 208,947

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Waleed Hassanein, M.D”): 24,024,298 for, 208,947 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 73% for, 0.7% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 99.9% of the shares they voted on this item FOR (18,260,335 for, 2 against).

FOR 99.9%
FOR: 18,260,335 (100.0%)AGAINST: 2 (0.0%)
Largest asset managers voting on “Election of Directors: Waleed Hassanein, M.D.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price220,3500 00For
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4140 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

3. Election of Directors: James R. Tobin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 23,518,088AGAINST: 711,239

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: James R. Tobin”): 23,518,088 for, 711,239 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 72% for, 2% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 99% of the shares they voted on this item FOR (18,038,994 for, 221,412 against).

FOR 99%
FOR: 18,038,994 (98.8%)AGAINST: 221,412 (1.2%)
Largest asset managers voting on “Election of Directors: James R. Tobin” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

4. Election of Directors: Edward M. Basile

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST 18%
FOR: 19,849,603AGAINST: 4,379,664

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edward M. Basile”): 19,849,603 for, 4,379,664 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 60% for, 13% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 88% of the shares they voted on this item FOR (16,060,751 for, 2,199,690 against).

FOR 88%12%
FOR: 16,060,751 (88.0%)AGAINST: 2,199,690 (12.0%)
Largest asset managers voting on “Election of Directors: Edward M. Basile” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,936,60821,632 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard1,794,429515,648 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie0828,083 00Against
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed0194,400 00Against
Brighthouse191,4131 00For
MERIDIAN FUND INC0171,714 00Against
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle0104,021 00Against
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

5. Election of Directors: Thomas J. Gunderson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 23,873,171AGAINST: 356,023

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Thomas J. Gunderson”): 23,873,171 for, 356,023 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 73% for, 1% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 99% of the shares they voted on this item FOR (18,039,825 for, 220,530 against).

FOR 99%
FOR: 18,039,825 (98.8%)AGAINST: 220,530 (1.2%)
Largest asset managers voting on “Election of Directors: Thomas J. Gunderson” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

6. Election of Directors: Edwin M. Kania, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 23,550,271AGAINST: 679,023

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edwin M. Kania, Jr.”): 23,550,271 for, 679,023 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 72% for, 2% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 99% of the shares they voted on this item FOR (18,039,086 for, 221,337 against).

FOR 99%
FOR: 18,039,086 (98.8%)AGAINST: 221,337 (1.2%)
Largest asset managers voting on “Election of Directors: Edwin M. Kania, Jr.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

7. Election of Directors: Stephanie Lovell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 23,789,019AGAINST: 441,905

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Stephanie Lovell”): 23,789,019 for, 441,905 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 72% for, 1% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 99% of the shares they voted on this item FOR (18,039,146 for, 221,225 against).

FOR 99%
FOR: 18,039,146 (98.8%)AGAINST: 221,225 (1.2%)
Largest asset managers voting on “Election of Directors: Stephanie Lovell” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

8. Election of Directors: Merilee Raines

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 23,928,824AGAINST: 302,040

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Merilee Raines”): 23,928,824 for, 302,040 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 73% for, 1.0% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 99% of the shares they voted on this item FOR (18,039,859 for, 220,530 against).

FOR 99%
FOR: 18,039,859 (98.8%)AGAINST: 220,530 (1.2%)
Largest asset managers voting on “Election of Directors: Merilee Raines” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

9. Election of Directors: David Weill, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 23,735,272AGAINST: 494,175

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: David Weill, M.D.”): 23,735,272 for, 494,175 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,851,376 outstanding shares: 72% for, 2% against (74% of the company cast a for/against vote).

The 82 asset managers below cast 99% of the shares they voted on this item FOR (18,039,232 for, 221,225 against).

FOR 99%
FOR: 18,039,232 (98.8%)AGAINST: 221,225 (1.2%)
Largest asset managers voting on “Election of Directors: David Weill, M.D.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
RWC Asset Management LLP3,894,9610 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

10. To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATED

Combines 5 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 80 asset managers below cast 99.9% of the shares they voted on this item FOR (14,193,625 for, 1,318 against).

FOR: 14,193,625 (100.0%)AGAINST: 1,318 (0.0%)
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered pu” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price220,3500 00For
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4140 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For
PROFESSIONALLY MANAGED PORTFOLIOS62,3300 00For

Showing the 25 largest of 80 asset managers. See all 80 in the interactive database.

11. Ratify PricewaterhouseCoopers LLP as Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,586,300 for, 0 against).

FOR: 3,586,300 (100.0%)
Largest asset managers voting on “Ratify PricewaterhouseCoopers LLP as Auditors” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,415,9000 00For
Capitol Series Trust170,4000 00For

Largest TRANSMEDICS GROUP INC. shareholders voting in 2023-2024

Ranked by the number of TRANSMEDICS GROUP INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 32,851,376 shares outstanding at the time of that meeting.

Top TRANSMEDICS GROUP INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 24.88%
2Vanguard 7.32%
3Invesco 4.96%
4BlackRock 4.03%
5MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 3.60%
6MUTUAL FUND SERIES TRUST 3.57%
7Allspring 2.93%
8ArrowMark Colorado Holdings LLC 2.70%
9Delaware/Macquarie 2.52%
10DRIEHAUS CAPITAL MANAGEMENT LLC 2.47%

Reported TRANSMEDICS GROUP INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TRANSMEDICS GROUP INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 16.23% 13F
FMR (Fidelity) 15.42% 13F
FMR LLC 14.94% DEF14A
Vanguard Group 10.98% 13F
Waleed Hassanein, M.D. 4.14% DEF14A
Invesco 3.90% 13F
State Street 2.36% 13F
Goldman Sachs 2.32% 13F
Geode Capital 2.20% 13F
Morgan Stanley 1.67% 13F

Percentages above are of 32,851,376 shares outstanding, as reported by TRANSMEDICS GROUP INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TRANSMEDICS GROUP INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At TRANSMEDICS GROUP INC.'s shareholder meeting held 2024-05-23, in the 2023-2024 proxy season, 281 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,832 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TRANSMEDICS GROUP INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-28.

TRANSMEDICS GROUP INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.